Windlas Biotech Quarterly Results for Trading Insights

WINDLAS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹18 Cr
QSept 2025
Quarterly Results

Windlas Biotech Quarterly Results Key Highlights

  • Revenue of ₹226 Cr in Sept 2025 (+8.7% vs Mar 2025, +17.7% vs Sept 2024)
  • Net Profit of ₹18 Cr in Sept 2025 (+12.5% vs Mar 2025, +12.5% vs Sept 2024)
  • EBITDA of ₹32 Cr in Sept 2025 (+3.2% vs Mar 2025)
  • Operating Margin of 13.0% in Sept 2025 (+0.0pp vs Mar 2025)
  • Earnings Per Share of ₹8.48 in Sept 2025 (+9.1% vs Mar 2025)

Windlas Biotech Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 226 208 215 238 192 8.7% 17.7%
Net Profit (₹ Cr) 18 16 18 15 16 - -
EBITDA (₹ Cr) 32 31 32 29 28 - -
EPS (₹) 8.48 7.77 8.43 7.12 7.49 - -
Operating Margin (%) 13.0% 13.0% 13.0% 10.0% 12.0% - -

Windlas Biotech Share Price Trend Around Quarterly Results

Visualize Windlas Biotech's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Windlas Biotech

Additional stock information and data for WINDLAS

WINDLAS share price
Windlas Biotech P/E valuation
WINDLAS price range

Profitability Ratios

Profit Margin 8.0%
EBITDA Margin 14.2%
Operating Margin 13.0%
ROE (Annual) 14.2%

Balance Sheet Highlights

Total Assets ₹761 Cr
Total Equity ₹506 Cr
Current Assets ₹525 Cr
Current Liabilities ₹5 Cr

Cash Flow Analysis

Operating Cash Flow ₹68 Cr
Investing Cash Flow ₹-74 Cr
Financing Cash Flow ₹1 Cr
Net Cash Flow ₹-5 Cr

Current Market Data

Current Price ₹764.50
Exchange NSE
Last Updated Apr 02, 2026

Revenue Trend (₹ Cr)

Dec 2025 238
Jun 2025 215
Mar 2025 208
Sept 2025 226

Net Profit Trend (₹ Cr)

Dec 2025 15
Jun 2025 18
Mar 2025 16
Sept 2025 18

Operating Margin Trend (%)

Dec 2025 10.0%
Jun 2025 13.0%
Mar 2025 13.0%
Sept 2025 13.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Windlas Biotech quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹406,351.37 Cr 1693.6 14,875 3,125 +10.8% - 21.0% 130.3
Divis Laboratories
Sept 2025 		₹155,471.67 Cr 5856.5 2,860 689 +7.1% - 24.1% 225.5
Torrent Pharmaceuti…
Sept 2025 		₹134,944.97 Cr 3987.2 3,219 591 +11.3% - 18.4% 227.3
Lupin
Sept 2025 		₹103,954.48 Cr 2274.5 6,921 1,485 +23.2% - 21.5% 70.3
Dr Reddys Laborator…
Sept 2025 		₹101,601.09 Cr 1217.3 9,135 1,337 +1.1% - 14.6% 75.2
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores